Trending Market News

Keurig Dr Pepper has appointed Rafael Oliveira, current CEO of JDE Peet's, as chief executive of its coffee operating unit as part of its $18 billion all-cash acquisition of the Dutch coffee and tea company announced in August. The combined entity will be split into two publicly traded U.S. companies—one for coffee and one for beverages—with the separation expected by year-end.

• Oliveira will lead the future coffee company following the planned separation, replacing the original candidate Sudhanshu Priyadarshi who left to become Mattel's CFO in November
• The $18 billion acquisition aims to help Keurig compete with industry leader Nestle and address high commodity costs
• Tim Cofer, Keurig's current chief, will become CEO of the future beverage company after the split

Meg O'Neill began as BP's new CEO on April 1, pledging consistency and accelerated performance as the oil major refocuses on oil and gas after abandoning renewable energy investments. She is BP's fourth CEO since 2020, its first external hire in over a century, and the first woman to lead a top-five oil major.

• BP has suspended share buybacks to prioritize debt reduction, targeting net debt of $14-18 billion by 2027 from current $22 billion, while pledging to divest $20 billion in assets
• O'Neill joins amid pressure from activist investor Elliott Investment Management, which has criticized BP's operational underperformance and pushed for portfolio reshaping
• The company has cut billions from planned renewable initiatives and pivoted strategy firmly back to oil and gas under new leadership including Chairman Albert Manifold

Tesla's new car registrations in France more than tripled in March 2026, reaching 9,569 vehicles—a 203% year-over-year increase and near its all-time high from December 2023. The surge signals a European sales recovery for the EV maker after it lost nearly half its market value in 2024, driven by new cheaper versions of Model Y and Model 3 launched late last year.

• March registrations of 9,569 vehicles were just below Tesla's all-time French record of 9,572 set in December 2023
• First-quarter 2026 registrations in France jumped 108% to 13,945 cars, accelerating from February's recovery
• The rebound follows Tesla's introduction of cheaper Model Y and Model 3 versions in the U.S. and Europe in late 2025

Australia's competition regulator granted interim approval for Qantas and American Airlines to continue their trans-Pacific partnership covering routes between Australia, New Zealand and North America. The carriers applied in November 2025 to extend their joint business agreement for five years, allowing coordination on fares, schedules, and inventory. A final determination is expected in June.

• The partnership covers trans-Pacific routes linking Australia and New Zealand with the U.S., Canada, and Mexico
• Under the agreement, the airlines coordinate on fares, schedules, inventory and related arrangements, with authorization sought for a five-year period
• The Australian Competition and Consumer Commission (ACCC) expects to issue a final determination in June after reviewing the application submitted November 24, 2025

Apple celebrates its 50th anniversary on Wednesday, having grown from a garage startup in 1976 to a tech giant with expected annual revenue of $465 billion. While the company has shaped the tech industry through innovations like the iPhone and integrated hardware-software ecosystems, it now faces pressure to compete in artificial intelligence, where rivals like Alphabet and Microsoft have taken early leads.

• Apple's stock is the second-worst performer among the 'Magnificent Seven' tech companies since ChatGPT's November 2022 launch, with analysts citing delays in AI features like a revamped Siri.
• The company expects $465 billion in revenue for fiscal year ending September 2026, driven by strong iPhone 17 demand and the $599 MacBook Neo, its cheapest laptop ever.
• Apple's services business (App Store, Apple Music, streaming) has become a major growth driver, providing steady subscription income from its expanding device base, though sparking disputes with companies like Epic Games over in-app payment control.

Anthropic accidentally leaked part of the internal source code for its coding assistant Claude Code due to a release packaging error caused by human error. The company confirmed no sensitive customer data or credentials were exposed, but the leak could provide competitors and developers insight into how the viral coding tool was built. This marks Anthropic's second major data incident in under a week.

• Claude Code has achieved significant commercial success with run-rate revenue exceeding $2.5 billion as of February 2026
• A post linking to Anthropic's leaked code accumulated over 21 million views, amplifying exposure of the internal source code
• This is Anthropic's second data blunder in less than a week, following the recent discovery of descriptions of upcoming AI models and other documents in a publicly accessible data cache

A federal judge ruled that Elon Musk must face a class action lawsuit over his delayed disclosure of a Twitter stake in 2022. Investors claim Musk violated SEC rules by waiting 11 days past the required deadline to disclose his 5% stake, allowing him to save over $200 million while causing losses to shareholders who sold at lower prices. The class action status exposes Musk to potentially greater damages than individual lawsuits would.

• Investors led by Oklahoma Firefighters Pension claim Musk saved more than $200 million by delaying disclosure while they sold Twitter shares at artificially low prices
• Judge Andrew Carter rejected Musk's argument that investors could not prove reliance on his fraud, citing the presumption that misrepresentations affected Twitter's stock price
• The case is separate from other Musk legal battles, including an SEC lawsuit over the same disclosure issue where settlement talks are reportedly underway

Nike reported third-quarter revenue of $11.28 billion, beating Wall Street estimates that predicted a 0.3% decline. The sportswear giant's performance was driven by turnaround efforts under CEO Elliott Hill, including tighter discount controls and new product launches, despite challenging consumer conditions and weak demand in China.

• Revenue remained flat year-over-year at $11.28 billion versus analyst expectations of $11.24 billion, representing a modest beat against predicted decline
• CEO Elliott Hill, appointed in October 2024, is leading a reset after years of heavy discounting, excess inventory, and uneven demand in key markets
• Nike continues facing headwinds from stagnant labor markets, rising credit card debt, and intensified competition in China from local rivals like Anta and Li Ning

Amazon settled charges with the National Labor Relations Board over allegations it retaliated against striking workers by illegally docking unpaid time off (UPT). The settlement will restore UPT to over 100 employees and requires Amazon to post notices at all 1,300 U.S. facilities informing workers of their right to organize, though Amazon denies any wrongdoing.

• Amazon illegally deducted unpaid time off from employees who participated in strikes, pushing some workers' UPT balances into negative territory and risking termination
• More than 100 employees will have their UPT restored, and Amazon agreed not to terminate or discriminate against workers who exceeded UPT limits due to strike participation
• The Teamsters union, which organized a December 2024 strike at seven Amazon delivery hubs and claims to represent nearly 10,000 Amazon workers, filed the charges leading to this settlement

Mercedes-Benz announced a $4 billion investment in its Alabama plant through 2030 to boost SUV production in response to significant U.S. auto tariffs. The German automaker plans over $7 billion in total U.S. investments, including a new research and development hub in Atlanta that will consolidate up to 500 jobs from various locations.

• $4 billion will be invested at the Alabama plant through 2030 specifically to increase SUV production capacity
• Total planned U.S. investment exceeds $7 billion across operations in coming years
• A new state-of-the-art R&D hub in Atlanta will consolidate up to 500 jobs from various U.S. locations

Nike is set to report fiscal third quarter earnings on Tuesday, with Wall Street expecting a steep decline in quarterly profit and flat sales as CEO Elliott Hill continues a turnaround effort approximately 18 months into his tenure. The company faces headwinds from a global trade war, rising Middle East tensions that could pressure consumer spending, and mixed regional performance including a 17% revenue decline in China last quarter.

• Analysts expect earnings per share of $0.39 and revenue of $11.24 billion for the fiscal third quarter
• Last quarter showed 9% sales growth in North America (Nike's largest market) but was offset by a 17% revenue drop in China
• Nike faces challenges from ongoing trade wars, potential inflation from Middle East conflict, and questions about sustainability of recent wholesale gains and whether consumers pulled forward purchases due to tariff concerns

The FDA has identified 76 cases of drug-induced liver injury, including 7 cases of vanishing bile duct syndrome and 8 deaths, linked to Amgen's Tavneos, a drug approved in 2021 for rare autoimmune diseases. The agency is urging healthcare providers to closely monitor patients and discontinue treatment if liver damage is suspected. This safety warning adds to existing regulatory concerns after the FDA requested voluntary withdrawal of the drug in January due to data integrity questions.

• The FDA identified 76 liver injury cases with 8 deaths, including 7 cases of vanishing bile duct syndrome, a rare condition causing permanent liver damage, with median onset of 46 days after starting treatment
• In January 2024, the FDA asked Amgen to voluntarily withdraw Tavneos due to concerns about primary endpoint data from 9 of 331 patients in the approval trial, but Amgen declined
• Both European and Australian labels warn of vanishing bile duct syndrome cases, but U.S. prescribing information currently does not include this warning

Meta Platforms launched two new Ray-Ban prescription smart glasses on Tuesday, expanding its AI-powered wearable offerings. The move targets the billions of people who wear glasses or contacts for vision correction, according to CEO Mark Zuckerberg. The Ray-Ban smart glasses have emerged as one of the few breakthrough successes in the AI gadget market.

• The new launches broaden prescription eyewear options in Meta's smart glasses lineup, which has become a rare success story among AI-powered consumer devices
• Meta CEO Mark Zuckerberg highlighted the massive addressable market, noting that 'billions of people wear glasses or contacts for vision correction'
• The expansion comes as Meta continues to invest in wearable technology and AI integration through its partnership with Ray-Ban

Warren Buffett acknowledged he sold Apple shares too soon and expressed willingness to buy more, but not at current market prices. Apple remains Berkshire Hathaway's largest holding despite the company reducing its stake to $61.96 billion by year-end. Buffett praised CEO Tim Cook's management while noting the stock isn't yet attractive even after falling more than 14% from recent highs.

• Berkshire has made over $100 billion pretax on Apple stock, which remains its largest holding even after trimming the position
• Buffett said Apple could reach a price where Berkshire would 'buy a lot of it,' but considers current market valuations too high
• Apple shares have dropped over 14% from recent highs and more than 6% this month amid broader market correction

Warren Buffett, 95, confirmed he remains actively involved in investment decisions at Berkshire Hathaway despite stepping down as CEO in early 2026. He disclosed making a 'tiny' new purchase and revealed Berkshire bought $17 billion in Treasury bills this week. The company held over $370 billion in cash equivalents at year-end.

• Buffett still comes to the office daily and calls Director of Financial Assets Mark Millard before market open to discuss trades, with CEO Greg Abel receiving daily investment updates
• Berkshire purchased $17 billion in Treasury bills at this week's auction, adding to its massive $370 billion cash equivalent position held largely in T-bills
• Buffett downplayed recent market volatility, noting Berkshire has seen three periods with 50%+ declines during his tenure and current conditions don't represent major buying opportunities

Nvidia has invested $2 billion in Marvell Technology and announced that Marvell will join the Nvidia AI ecosystem. The partnership will enable Marvell to more easily design custom artificial intelligence solutions using its own networking gear and processors.

• Nvidia's investment in Marvell totals $2 billion, representing a significant capital commitment to the partnership
• Marvell will integrate into Nvidia's AI ecosystem, facilitating the design of custom AI solutions
• The collaboration focuses on combining Marvell's networking equipment and processors with AI capabilities

Novo Nordisk launched a discounted subscription plan for U.S. self-pay Wegovy patients, offering monthly prices up to nearly 30% below standard rates as it competes with Eli Lilly's Zepbound in the obesity drug market. The program, available through telehealth platforms starting Tuesday, aims to retain patients, counter cheaper compounded alternatives, and adapt to a more consumer-focused market. Analysts warn Novo risks losing ground in a price war as both companies shift to direct-to-consumer sales strategies.

• Wegovy subscriptions range from $249-$329 monthly (6-29% discount) depending on commitment length, while Lilly's Zepbound starts at $299/month for lower doses
• The move follows Novo's November 2024 price cut from $499 to $349 monthly and represents a strategic pivot to telehealth partnerships with Ro, WeightWatchers, and LifeMD
• Both drugmakers are competing to steer patients from cheaper compounded copies to FDA-approved branded drugs while adapting to patients becoming 'consumers of health' who pay out-of-pocket

Britain's Competition and Markets Authority (CMA) announced it will launch an antitrust investigation into Microsoft's business software ecosystem in May, focusing on software licensing practices in the cloud market. The probe could result in Microsoft being assigned 'strategic market status' in business software, granting the regulator enhanced enforcement powers.

• The CMA previously identified that the dominance of Amazon and Microsoft was harming competition in cloud computing
• Both Microsoft and Amazon are taking 'material steps' to lower some cloud market fees in response to regulatory pressure
• If Microsoft is designated with 'strategic market status' in business software, the CMA would gain authority to directly act on its software licensing practices

Biogen has agreed to acquire Apellis Pharmaceuticals in an all-cash transaction valued at approximately $5.6 billion. The deal was announced on March 31 and represents a significant consolidation move in the biopharmaceutical sector. The acquisition will expand Biogen's portfolio and market presence.

• The transaction is structured as an all-cash deal worth $5.6 billion
• Biogen is acquiring Apellis Pharmaceuticals, adding the company's assets and pipeline to its portfolio
• The deal represents a major M&A move in the pharmaceutical industry as companies seek to expand therapeutic offerings

Eli Lilly announced it will acquire Centessa Pharmaceuticals in a deal valued at approximately $6.3 billion. The acquisition aims to advance Eli Lilly's portfolio in treatments for sleep-wake disorders.

• The transaction is worth about $6.3 billion, representing a significant investment in specialty therapeutics
• The deal focuses on expanding Eli Lilly's capabilities in sleep-wake disorder treatments
• The acquisition was announced on March 31 and adds Centessa's pipeline to Lilly's existing pharmaceutical portfolio